Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Arcturus Therapeutics Holdings (ARCT) Receivables - Other (2018 - 2025)

Arcturus Therapeutics Holdings' Receivables - Other history spans 8 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 44.16% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, up 44.16%, while the annual FY2025 figure was $3.6 million, 44.16% up from the prior year.
  • Receivables - Other reached $3.6 million in Q4 2025 per ARCT's latest filing, down from $8.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $92.5 million in Q1 2023 to a low of $2.0 million in Q1 2021.
  • Average Receivables - Other over 5 years is $15.7 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Receivables - Other: surged 2405.64% in 2023, then plummeted 92.2% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $3.4 million in 2021, then fell by 17.91% to $2.8 million in 2022, then skyrocketed by 1060.06% to $32.1 million in 2023, then tumbled by 92.2% to $2.5 million in 2024, then soared by 44.16% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Receivables - Other are $3.6 million (Q4 2025), $8.0 million (Q3 2025), and $17.2 million (Q2 2025).